Transdermal drug delivery device
A transdermal drug delivery device is disclosed that may comprise a housing including an upper housing portion and a lower housing portion. The lower housing portion may define a bottom surface including skin attachment means for releasably attaching the lower housing portion to skin of a user. The upper housing portion may at least partially surround a central region of the device. The device may also include a microneedle assembly and a reservoir disposed within the central region. The reservoir may be in fluid communication with the microneedle assembly. Additionally, the device may include a pushing element disposed above the microneedle assembly within the central region. The pushing element may be configured to provide a continuous bilateral force having a downward component transmitted through the microneedle assembly and an upward component transmitted through the skin attachment means.
1. A drug delivery device comprising:
an outer housing including an upper housing portion and a lower housing portion, the lower housing portion extending from the upper housing portion and having a bottom surface for contacting a user's skin when the drug delivery device is in use;
the drug delivery device including a central region, an outer region defined by an outer periphery of the lower housing portion at a location at which the drug delivery device contacts the user's skin during use; and an intermediate region extending between and separating the central region and the outer region;
a microneedle assembly disposed within the central region;
a reservoir disposed within the central region and above the microneedle assembly, the reservoir containing a drug formulation and being in fluid communication with the microneedle assembly when the drug delivery device is in use;
a plunger disposed within the central region; and
a pushing element configured to move the drug delivery device from an un-actuated position to an actuated position,
wherein in the un-actuated position
1) the plunger is vertically aligned with and positioned above the reservoir and the microneedle assembly, and
2) the microneedle assembly is recessed relative to the bottom surface of the lower housing portion and spaced from the user's skin, and
wherein in the actuated position
1) the plunger is moved relative to the outer housing by the pushing element to apply a force against the reservoir to thereby move both the reservoir and the microneedle assembly downward such that the microneedle assembly is moved into direct contact with the user's skin, and
2) the plunger acts on the reservoir, after the microneedle assembly is moved into direct contact with the user's skin, to push the drug formulation from the reservoir to the microneedle assembly.
2. The drug delivery device of claim 1 , wherein the reservoir includes a flexible member, and wherein the force applied by the plunger pressurizes the reservoir.
3. The drug delivery device of claim 2 , and wherein the force applied by the plunger acts on the drug formulation within the reservoir.
4. The drug delivery device of claim 1 , wherein the reservoir is configured as a rigid member containing the drug formulation, and wherein the force applied by the plunger is transmitted through the microneedle assembly without increasing pressure of the drug formulation contained within the reservoir.
5. The drug delivery device of claim 1 , wherein the force applied by the plunger is transmitted through the central region to the microneedle assembly, and wherein an opposing force is simultaneously transmitted through the central region to the upper housing portion.
6. The drug delivery device of claim 1 , wherein the pushing element comprises a spring compressed between the upper housing portion and the reservoir.
7. The drug delivery device of claim 6 , wherein the spring is compressed between the upper housing portion and the plunger.
8. The drug delivery device of claim 1 , wherein no force is substantially transmitted through the intermediate region.
9. A drug delivery device comprising:
an upper housing portion attached to a lower housing portion;
a microneedle assembly;
the upper housing portion and the lower housing portion cooperatively defining a cavity and surrounding the microneedle assembly, the drug delivery device being configured such that the lower housing portion is dissociated from the microneedle assembly;
a reservoir disposed within the cavity and being in fluid communication with the microneedle assembly;
a plunger disposed within a central region of the drug delivery device; and
a pushing element configured to move the drug delivery device from an un-actuated position to an actuated position,
wherein in the un-actuated position
1) the plunger is vertically aligned with and positioned above the reservoir and the microneedle assembly, and
2) the microneedle assembly is recessed relative to a bottom surface of the lower housing portion and spaced from a user's skin, and
wherein in the actuated position
1) the plunger is moved relative to the upper housing portion by the pushing element to apply a force against the reservoir to thereby move both the reservoir and the microneedle assembly downward such that the microneedle assembly is moved into direct contact with the user's skin, and
2) the plunger acts on the reservoir, after the microneedle assembly is moved into direct contact with the user's skin, to push a drug formulation from the reservoir to the microneedle assembly.
10. The drug delivery device of claim 9 , wherein the reservoir contains the drug formulation, and wherein the force is transmitted through the microneedle assembly without increasing pressure of the drug formulation within the reservoir.
11. The drug delivery device of claim 10 , wherein the reservoir is disposed between the microneedle assembly and the pushing element, and wherein the force applied by the plunger is transmitted through the reservoir to the microneedle assembly.
12. The drug delivery device of claim 9 , wherein the pushing element comprises, prior to actuation, a compressed member.
13. The drug delivery device of claim 9 , wherein the upper housing portion defines an opening, and wherein a top portion of the pushing element extends through the opening, the top portion being movable relative to the upper housing portion, and wherein application of a downward force on the top portion transmits a further downwardly force against the microneedle assembly.
14. The drug delivery device of claim 9 , wherein the microneedle assembly, the reservoir, and the pushing element are vertically aligned.
15. A drug delivery device comprising:
a central region, an outer region surrounding the central region, and an intermediate region disposed between the central region and the outer region, the drug delivery device comprising:
a microneedle assembly disposed within the central region of the drug delivery device;
a reservoir disposed within the central region, wherein the reservoir contains a drug formulation, and wherein the reservoir is in selective fluid communication with the microneedle assembly; and
a pushing element disposed above both the reservoir and the microneedle assembly within the central region, the pushing element being configured to provide a force having a downward component to move the microneedle assembly into engagement witha user's skin,
wherein the reservoir is disposed between the microneedle assembly and the pushing element, and wherein the downward component of the force from the pushing element is transmitted through the reservoir to the microneedle assembly without increasing pressure of the drug formulation within the reservoir.
16. The drug delivery device of claim 15 , further comprising a housing including an upper housing portion and a lower housing portion, and wherein the microneedle assembly is configured to move independently of the lower housing portion.
17. The drug delivery device of claim 15 , further comprising a housing including an upper housing portion and a lower housing portion, and wherein the pushing element comprises a spring compressed between the upper housing portion and the reservoir.
18. The drug delivery device of claim 15 , wherein no force is substantially transmitted through the intermediate region.